Skip to main content
SpringerLink
Log in
Book cover

Etoposid (VP 16-213) in der Therapie maligner Erkrankungen pp 76–85Cite as

Neue Zytostatikakombination mit Etoposid bei Morbus Hodgkin

  • Chapter

Zusammenfassung

Es wird erstmals über die vorläufigen Ergebnisse des LEAMP-Protokolls berichtet. Das Schema wurde im April 1982 erstmals bei einem Patienten eingesetzt, welcher wegen eines progredienten Lungenbefalls von M. Hodgkin an der III. Medizinischen Abteilung des Hanusch-Krankenhauses in Behandlung stand und gegen alle bisherigen Chemotherapieschemata resistent war. Nach Applikation der neuen Zytostatikakombination war es zu einer überraschenden Rückbildung der Lungeninfiltrate gekommen; die Kombination wurde daher in der Folge bei ähnlich gelagerten Fällen regelmäßig eingesetzt.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. SOBA11112402456Achterrath, W., Niederle, N., Raettig, R., Hilgard, P: Etoposide — chemistry, preclinical and clinical pharmacology. Cancer Treat. Rev. 9, Suppl. A, 3 (1982).

    Article  PubMed  Google Scholar 

  2. Bonadonna, G., De Lena, M., Monfardini, S., Rossi, A., Brambilla, C., Uslenghi, C., Zucali, R: Combination usage of Adriamycin (NSC-123127) in malignant lymphomas. Cancer Chemother. Rep. 6, 381 (1975).

    Google Scholar 

  3. Case, D. C., Jr., Young, C. W., Lee III, B. J: Combination chemotherapy of MOPP-resistant Hodgkin’s disease with Adriamycin, Bleomycin, Dacarbazine, and Vinblastin (ABVD). Cancer 39, 1382 (1977).

    Article  PubMed  Google Scholar 

  4. Coltman, C. A. Jr.: Chemotherapy of advanced Hodgkin’s disease. Sem. Oncol. 7, 155 (1980).

    Google Scholar 

  5. Hansen, H. H., Selawry, O. S., Pajak, T. F., Spurr, C. L., Falkson, G., Brunner, K., Cuttner, J., Nissen, N. I., Holland, J. F: The superiority of CCNU in the treatment of advanced Hodgkin’s disease: Cancer and Leukemia Group B Study. Cancer 47, 14 (1981).

    Article  PubMed  CAS  Google Scholar 

  6. Issel, B. F., Crooke, S. T: Etoposide (VP 16-213). Cancer Treat. Rev. 6, 107 (1979).

    Article  Google Scholar 

  7. Kroner, T., Obrecht, J. P., Jungi, W. F: Etoposide as single agent and in combination with cis-platin for malignant lymphomas. Cancer Treat. Rev. 9, Suppl. A, 39 (1982).

    Article  PubMed  Google Scholar 

  8. Mathe, G., Schwarzenberg, L., Pouillart, P., Oldham, R., Weiner, R., Jasmin, C., Rosenfeld, C., Hayat, M., Misset, J. L., Musset, M., Schneider, M., Amiel, J. L., De Vassal, F: Two epipodophyllotoxin derivates VM 26 and VP 16-213 in the treatment of leukaemias, haematosarkomas, and lymphomas. Cancer 34, 985 (1974).

    Article  PubMed  CAS  Google Scholar 

  9. Mead, G. M., Harker, W. G., Kushlan, P., Rosenberg, S. A: Single agent palliative chemotherapy for end-stage Hodgkin’s disease. Cancer 50, 829 (1982).

    Article  PubMed  CAS  Google Scholar 

  10. Nissen, N. I., Pajak, T. F., Leone, L. A., Bloomfield, C. D., Kennedy, B. J., Ellison, R. R., Silver, R. T., Weiss, R. B., Cuttner, J., Falkson, G., Kung, F., Bergevin, P. R., Holland, J. F: Clinical trial of VP 16-213 (NSC 141540) i.v. twice weekly in advanced neoplastic disease. A study by the Cancer and Leukemia Group B. Cancer 45, 232 (1980).

    Article  PubMed  CAS  Google Scholar 

  11. Porzig, K. J., Portlock, C. S., Robertson, A., Rosenberg, S. A: Treatment of advanced Hodgkin’s disease with B-CAVe following MOPP failure. Cancer 41, 1670 (1978).

    Article  PubMed  CAS  Google Scholar 

  12. Santoro, A., Bonadonna, G: Prolonged disease-free survival in MOPP-resistant Hodgkin’s disease after treatment with Adriamycin, Bleomycin, vinblastine and dacarbazine (ABVD). Cancer Chemother. Pharmacol. 2, 101 (1979).

    CAS  Google Scholar 

  13. Schmoll, H. J., Niederle, N., Achterrath, W: Etoposid (VP 16-213). Eine antineoplastische Substanz aus der Reihe der Podophyllotoxine. Klin. Wschr. 59, 1177 (1981).

    Article  PubMed  CAS  Google Scholar 

  14. Schmolly H: Review of etoposide single-agent activity. Cancer Treat. Rev. 9, Suppl. A, 21 (1982).

    Article  Google Scholar 

  15. von Heyden, A. W., Scherpe, A., Nagel, G. A: Cis-dichlorodiammine- platinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas. Cancer Treat. Rev. 9, Suppl. A, 45 (1982).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ludwig Boltzmann-Institut für Leukämieforschung und Hämatologie und III. Medizinische Abteilung, Hanusch-Krankenhauses, Wien, Austria

    G. Linemayr, R. Waldner, G. Baumgartner & R. Heinz

  2. Berlin, Deutschland

    Hellriegel

  3. Zürich, Switzerland

    Hofmann

  4. Wien, Austria

    Honetz,  Karrer,  Kühböck,  Neumann,  Schwarzmeier &  Stacher

  5. Neu-Isenburg, Germany

    Raettig

  6. Innsbruck, Austria

    Schmalzl

  7. Graz, Austria

    Seewann

Authors
  1. G. Linemayr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Waldner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Baumgartner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Heinz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hellriegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Honetz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Karrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kühböck
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Neumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Raettig
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Schmalzl
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Schwarzmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Seewann
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Stacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. I. Medizinischen Universitätsklinik, Wien, Austria

    Josef Schwarzmeier (Oberarzt) & Erwin Deutsch (Vorstand) (Oberarzt) &  (Vorstand)

  2. Gemeinsame Institutseinrichtung für Epidemiologie der Neoplasmen, Universität Wien, Austria

    Karl Karrer

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag/Wien

About this chapter

Cite this chapter

Linemayr, G. et al. (1984). Neue Zytostatikakombination mit Etoposid bei Morbus Hodgkin. In: Schwarzmeier, J., Deutsch, E., Karrer, K. (eds) Etoposid (VP 16-213) in der Therapie maligner Erkrankungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8755-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-8755-5_9

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-81801-5

  • Online ISBN: 978-3-7091-8755-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation